These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9876209)

  • 1. A new fluoroquinolone derivative exhibits inhibitory activity against human immunodeficiency virus type 1 replication.
    Kashiwase H; Momota K; Ohmine T; Komai T; Kimura T; Katsube T; Nishigaki T; Kimura S; Shimada K; Furukawa H
    Chemotherapy; 1999; 45(1):48-55. PubMed ID: 9876209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents.
    Hagihara M; Kashiwase H; Katsube T; Kimura T; Komai T; Momota K; Ohmine T; Nishigaki T; Kimura S; Shimada K
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3063-8. PubMed ID: 10560726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Okamoto M; Okamoto T; Baba M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species.
    Baba M; Okamoto M; Takeuchi H
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2350-5. PubMed ID: 10508005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
    Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
    Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
    Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
    Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
    Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
    Witvrouw M; Daelemans D; Pannecouque C; Neyts J; Andrei G; Snoeck R; Vandamme AM; Balzarini J; Desmyter J; Baba M; De Clercq E
    Antivir Chem Chemother; 1998 Sep; 9(5):403-11. PubMed ID: 9875393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin mannich bases.
    Pandeya SN; Sriram D; Nath G; De Clercq E
    Eur J Med Chem; 2000 Feb; 35(2):249-55. PubMed ID: 10758286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term culture of HIV-1-infected cells with the transcription inhibitor K-37.
    Yamataka K; Wang X; Baba M
    Antiviral Res; 2002 Oct; 56(1):85-92. PubMed ID: 12323402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
    Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
    Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives.
    Baba M; Okamoto M; Makino M; Kimura Y; Ikeuchi T; Sakaguchi T; Okamoto T
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1250-5. PubMed ID: 9174179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4)(H2O)16(Mo7O24)4).13H2O on human immunodeficiency virus type 1.
    Inouye Y; Tokutake Y; Yoshida T; Seto Y; Hujita H; Dan K; Yamamoto A; Nishiya S; Yamase T; Nakamura S
    Antiviral Res; 1993 Apr; 20(4):317-31. PubMed ID: 8387260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
    Nozaki-Renard J; Iino T; Sato Y; Marumoto Y; Ohta G; Furusawa M
    Cell Struct Funct; 1990 Oct; 15(5):295-9. PubMed ID: 2085844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
    Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).
    Gulakowski RJ; McMahon JB; Buckheit RW; Gustafson KR; Boyd MR
    Antiviral Res; 1997 Jan; 33(2):87-97. PubMed ID: 9021050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.